'MS' 'Multiple Sclerosis'
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For PwMS: • Confirmed relapse onset MS diagnosis according to the McDonald 2017 criteria • Expanded Disability Status Scale (EDSS) score = 3 months • unchanged therapy for >= 2 months at time of inclusion. • Age 18-65 years • Language: Dutch • Pregnancy • Inability to use the right hand For healthy controls: • Age 18-65 years • Language: Dutch • Pregnancy • Inability to use the right hand
Exclusion criteria
Exclusion criteria: see inclusion criteria D4a.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main endpoint measure of the study is the regional task-based Blood Oxygen Level Dependent (BOLD) response measured by fMRI during a visual and verbal WM task paradigm with delayed distraction and distraction at encoding compared to the control condition without distraction (14). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints measure target the behavioural and neural differences between PwMS and healthy controls in the visual and verbal WM task paradigm with delayed distraction and distraction at encoding. • Differences in regional task-based BOLD response changes measured by fMRI during a visual and verbal WM task paradigm with delayed distraction and distraction at encoding between PwMS and healthy controls • Differences in task performance of visual and verbal WM with delayed distraction and distraction at encoding between PwMS and healthy controls • Differences in resting state brain activity between PwMS and healthy controls Other study parameters include: • Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS(27)) in order to assess cognitive functioning in PwMS • Forward and backward digit span (WAIS-IV (28)) to assess phonological WM performance in all participants • Corsi Block Tapping Test (29,30) to assess visuospatial WM performance in all participants • Sensory Processing Sensitivity Questionnaire (38) to assess sensory processing sensitivity in all participants | — |
Countries
Netherlands